Skip to content

Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation.

Epileptogenic Zone's Cartography by Quantification of EEG's Signal and Intracerebral Stimulation.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02844374
Acronym
EPISTIM
Enrollment
45
Registered
2016-07-26
Start date
2014-01-31
Completion date
2017-01-31
Last updated
2016-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Keywords

Epilepsy, Surgery candidate, EEG's Signal

Brief summary

Epilepsy is a devastating chronic disease due to multiple causes that affect close to 50% of the world's population. Although effective, epilepsy surgery fails in many cases, the percentage of patients free from crisis on a long term (≥ 5 years) varies from 27% to 66% according to the kind of epilepsy. It is in this context that EPISTIM is interesting, and its aims isb a better electrophysiology delimiting of cortical networks that imply the genesis of seizures with the aim to improove surgery results. This study will rely on the intracerebral records and on corticales electrical stimulation as they are currently routinely used by epileptic patients candidates for surgery.

Interventions

OTHERFunctional stereotaxic exploration

Visual analysis : in order to define the level of cortical resections. Epileptogenic maps : calculated for each crisis and for all crisis in general. Connectivity maps : calculated for each site stimulated at low-frequency. Post-operative evaluation : in order to assess the extent of resection.

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

: * Patient from 5 to 65 years (L1121-7 L1122 2 CSP), including legally protected or unable to give his consent (L1121-8 CSP). * Written approval of inclusion in the study from the patient or his legal representative. * Patients with partial Epilepsy Drug Resistant , justifying a SEEG exploration.

Exclusion criteria

: * Patient under 5 years. * Patient over 65 years. * Pregnant or breastfeeeding women (L1121-5 CSP). * Patient deprived of liberty as a result of a judicial or administrative decision (L1121-6 CSP). * Patients over 18 years unable to give their free consent and not subject to a legal protection order.

Design outcomes

Primary

MeasureTime frameDescription
Visual analysisup to one hourVisual analysis : in order to define the level of cortical resections.
Epileptogenic mapsup to 10 minEpileptogenic maps : calculated for each crisis and for all crisis in general.
Connectivity mapsup to 10 minConnectivity maps : calculated for each site stimulated at low-frequency.
MRIup to one hourPost-operative evaluation : in order to assess the extent of resection. MRI : 3D-T1

Countries

France

Contacts

Primary ContactPhilippe Kahane, Professor
philippe.kahane@ujf-grenoble.fr04.76.76.54.48
Backup ContactLorella Minotti, Hospital Practitioner
Lminotti@chu-grenoble.fr0476765448

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026